White matter hyperintensities, cognitive impairment and dementia: an update

By N. Prins, Philip Scheltens. Nature Reviews Neurology, 2015

1,180 citations recorded by the source corpus.

Subfields: Neurology, Psychiatry and Mental health, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/6b53aac5c5b4df6f824f5d0c989b266f0d8534ec

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Neurology

1. Sébastien Ourselin
2. Mark Jenkinson

In Psychiatry and Mental health

1. Frederik Barkhof
2. W. M. van der Flier
3. C. Iadecola

In Pulmonary and Respiratory Medicine

1. Peter M. Rothwell

Citations in the corpus

• White matter changes in Alzheimer’s disease: a focus on myelin and oligodendrocytes (2018, neutral): “These white matter changes are believed to reflect demyelination and axon damage [63].”
• Standardized Assessment of Automatic Segmentation of White Matter Hyperintensities; Results of the WMH Segmentation Challenge (2019, background): “These measures are associated with the presence and severity of clinical symptoms, such as cognitive impairment and gait disturbances, and are likely to find their way into daily clinical practice, supporting diagnosis, prognosis, and treatment monitoring [2], [4].”
• BIANCA (Brain Intensity AbNormality Classification Algorithm): A new tool for automated segmentation of white matter hyperintensities (2016, background): “…et al., 2012), and are associated with increased risk of functional decline, dementia, and death (de Groot et al., 2000; Debette and Markus, 2010; Inzitari et al., 2009; Jeerakathil et al., 2004; Longstreth et al., 1996; Pantoni et al., 2005; Prins and Scheltens, 2015; van Dijk et al., 2002).”